Civica Rx ANDA Statement

Civica Rx today announced that it is interested in talking to generic drug manufacturers who are considering retiring or withdrawing their Abbreviated New Drug Applications (ANDAs) for essential medicines that are at risk of being in short supply. Periodically, the FDA withdraws approvals of ANDAs due to manufacturer inactivity. According to published reports, the...

Civica Rx and Hikma Announce Shipments of Heparin and Seven other Essential Injectable Medicines

Civica Rx and Hikma Pharmaceuticals, the multinational generic pharmaceutical company, today announced imminent shipments of Heparin Sodium Injection, USP, and seven other essential injectable medicines, with additional products to follow in the near term in the US through its affiliate, Hikma Pharmaceuticals USA Inc. Today's announcement comes as industry experts work to avoid an...

Recent Recognition

Fast Company lists Civica as one of The World's 50 Most Innovative Companies for manufacturing generic drugs at lower prices to combat shortages and rising healthcare costs. Modern Healthcare names Martin VanTrieste, President and CEO of Civica Rx, as one of The 100 Most Influential People in Healthcare. “This recognition is a reflection of everything the...

Civica Rx Celebrates Its First Birthday!

Overheard at a recent Congressional Hearing on the reliability of the global generic drug supply chain: “I think it is fascinating to watch what the private sector hospitals in the United States are doing…they formed a nonprofit called Civica Rx in response to persistent shortages of vital life-saving medicines…and they are doing direct contracting with trustworthy manufacturers…with...

Scroll to top